When activated PLT is combined with tumor cells, PLT can prevent tumor cells from being detected and attacked by human immune cells and produce vascular endothelial growth factor and transforming growth factor beta to promote the growth of tumor cells. This evidence concerns the gene VEGFA and neoplasm.